Navigation Links
New non-surgical treatment for uterine fibroids can improve quality of life
Date:6/30/2010

Rome, Italy: A new, effective, non-surgical treatment for uterine fibroids can help women with this condition maintain their fertility, an American scientist told the 26th annual meeting of the European Society of Human Reproduction and Embryology in Rome today (Wednesday). Dr. Alicia Armstrong, Chief, Gynecologic Services, National Institutes of Health (NIH) Programme in Reproductive and Adult Endocrinology, Bethesda, Maryland, said that the outcome of two Phase II clinical trials of ulipristal acetate (UPA) had significant implications for both infertility and general gynaecology patients.

UPA belongs to a relatively new class of drug, the selective progesterone receptor modulators or SPRMs. It is currently used for emergency contraception, and acts by blocking the progesterone receptor and hence ovulation (release of the egg). Recent research has shown that progesterone also plays a role in the development of uterine fibroids, which affect 24 million women in Europe and can lead to a range of symptoms such as abdominal pain and discomfort and heavy and irregular menstrual bleeding. Fibroids are the major indication for hysterectomy in Europe and the US, and they also contribute to infertility by interfering with the ability of the embryo to implant in the womb and causing miscarriage.

"Both the fibroids and the surgical interventions commonly used to treat them can cause significant fertility problems," said Dr. Armstrong, "and we wanted to see whether fibroids could shrink and surgery could be avoided by using an SPRM."

Results from two Phase II randomised, placebo-controlled, double-blinded studies performed at NIH were pooled and analysed. In the trials, women aged from 25-50 years with symptomatic uterine fibroids were randomised to receive UPA or placebo once a day for three menstrual cycles. The researchers found that, out of the 57 patients who it was possible to evaluate for efficacy, 18 received placebo, 20 10mg of UPA
'/>"/>

Contact: Mary Rice
mary@mrcommunication.org
European Society of Human Reproduction and Embryology
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Medical Ultrasound Now Used in New, Non-surgical Cosmetic Procedure
2. 50+ and Fabulous: Three Non-Surgical Procedures Effectively Reverse the Signs of Aging
3. Achieve Hollywood Glamour with Non-Surgical Cosmetic Procedures
4. Dr. Alexander Rivkin's Pioneering Non-Surgical Nose and Eye Transformations Are Making Headlines and May Be Permanent Solutions
5. Steroids May Be Overrated in Treatment of COPD
6. Experimental stem cell treatment arrests acute lung injury in mice, study shows
7. Entest BioMedical Enters into LOI with Advanced Light Devices to Develop Laser Platform for Stem Cell / Laser COPD Treatment
8. New study shows effectiveness of MEND program in prevention and treatment of pediatric obesity
9. New York City Surgeon Develops All-Natural Treatment for Wrinkles and Scars
10. Novelty lures rats from cocaine-paired settings, hinting at new treatments for recovering addicts
11. Northeast Chiropractic, PC Revolutionizes Pain Management Without Medication, Now Offering New and Unique Blend of Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2012)... MAYWOOD, Ill. -- Children born with cleft lip, ... medical challenges beyond appearance. , Patients can face ... well as social and psychological challenges, Laura Swibel ... colleagues write in the June 2012 issue of ... "The management of patients with craniofacial syndromes is ...
(Date:5/22/2012)... began last year when the U.S. Preventive Services Task ... prostate-cancer tests to healthy men continued this week when ... stuck to their guns, stating that a blood test ... test, causes more harm than good it leads ... , But many people simply don,t believe that the ...
(Date:5/22/2012)... HealthDay Reporter , , TUESDAY, May 22 (HealthDay News) ... with earlier development of precancerous colon lesions recommend people ... a younger age than others. "Based on our ... screenings earlier, possibly at age 40, rather than at ... fellow at Washington University in St. Louis. However, ...
(Date:5/22/2012)... (HealthDay News) -- Healthier lifestyles and better disease management ... Americans with diabetes between 1997 and 2006, especially ... federal government report shows. During that time, deaths ... 23 percent and deaths caused by heart disease and ... to the analysis of 1997-2004 National Health Interview Survey ...
(Date:5/22/2012)... Pushed to the brink of survival, the hyper-driven cells ... that has helped organisms cope with internal stresses and ... part of this system, heat shock protein 90 (HSP90) ... genetic changes and profound disturbances in normal biology that ... inhibiting HSP90 just might render breast cancer cells less ...
Breaking Medicine News(10 mins):Health News:Cleft lip/palate cause much more than cosmetic problems 2Health News:Psychological Science explains uproar over prostate-cancer screenings 2Health News:Middle-Aged Diabetics May Need Earlier Colon Checks 2Health News:Middle-Aged Diabetics May Need Earlier Colon Checks 3Health News:U.S. Sees Drop in Deaths Linked to Diabetes 2Health News:U.S. Sees Drop in Deaths Linked to Diabetes 3Health News:Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy 2Health News:Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy 3
... remains focused on expanding business, CHICAGO, Nov. ... writing medical malpractice insurance in Illinois despite a,Cook ... tort,reform law which placed caps on awards for ... decision to be a major player in,Illinois for ...
... YORK, November 14 On the first United ... calls on,governments to develop national policies for the ... donors worldwide to consider the need,for a diabetes ... Speaking at the World Diabetes Day press ...
... prevention programs targeting high-risk groups, SEATTLE, Nov. ... today that it will commit $50 million to ... organizations to expand HIV,prevention efforts in China. The ... those most vulnerable to infection, including,injection drug users, ...
... In either an,inadvertent omission or a betrayal ... Nunez lacks any mention of the tax,credits he ... that is otherwise unaffordable, said the Foundation for ... concern that though the funding source for,expansion of ...
... Board of Regents of ACS publishes commentary in JAMA, ... Surgeons added,its voice to a commentary on the surgeon ... of the American Medical Association (JAMA). The,article, "The Impending ... Fischer, MD, FACS, chair of the College,s Board of ...
... Nexus CGH with Illumina,s BeadStudio Software -, ... BioDiscovery announced,today that it joined Illumina Connect, ... downstream analysis of microarray data. After,collaborating with ... allows customers using both Illumina,s BeadStudio software,to ...
Other Medicine News:Health News:New Med Mal Insurance Company Medicus to Stay in Illinois 2Health News:First United Nations World Diabetes Day Unites Global Diabetes Community to Fight the Epidemic 2Health News:First United Nations World Diabetes Day Unites Global Diabetes Community to Fight the Epidemic 3Health News:First United Nations World Diabetes Day Unites Global Diabetes Community to Fight the Epidemic 4Health News:Gates Foundation Commits to Expansion of HIV Prevention in China 2Health News:Gates Foundation Commits to Expansion of HIV Prevention in China 3Health News:Nunez Health Reform Bill Establishes Mandatory Purchase Without Linking to Subsidies for Middle Class and Poor 2Health News:Nunez Health Reform Bill Establishes Mandatory Purchase Without Linking to Subsidies for Middle Class and Poor 3Health News:Nunez Health Reform Bill Establishes Mandatory Purchase Without Linking to Subsidies for Middle Class and Poor 4Health News:Nunez Health Reform Bill Establishes Mandatory Purchase Without Linking to Subsidies for Middle Class and Poor 5Health News:Nunez Health Reform Bill Establishes Mandatory Purchase Without Linking to Subsidies for Middle Class and Poor 6Health News:Nunez Health Reform Bill Establishes Mandatory Purchase Without Linking to Subsidies for Middle Class and Poor 7Health News:American College of Surgeons Comments on JAMA Article on Surgeon Shortage 2Health News:BioDiscovery Joins Illumina Connect Bioinformatics Program 2
(Date:5/23/2012)... 2012 QRxPharma Limited (ASX: QRX and OTCQX: ... Trademark Office (USPTO) issued the Company U.S. Patent No. ... covers a method of treatment of pain comprising the ... compositions of MoxDuo IR (Immediate Release) for the ... (Controlled Release) for the treatment of chronic pain. ...
(Date:5/23/2012)... Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced ... phase 2 clinical trial, T reatment with ... E fficacy T rial (TARGET-NTM), ... non-tuberculous mycobacterial (NTM) lung disease. There ... NTM treatment recommendations, and no new drugs have been ...
(Date:5/23/2012)... 2012  Isis Pharmaceuticals, Inc. (NASDAQ: ... presented at EAS 2012When:Friday, June 1st at 12:00 ... Internet.  Simply log onto our Web site listed ... the live event, a replay of the webcast ... www.isispharm.com . ABOUT ISIS ...
Breaking Medicine Technology:QRxPharma Granted Additional US Patent on MoxDuo® 2QRxPharma Granted Additional US Patent on MoxDuo® 3Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease 2Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease 3Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease 4Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease 5TPI Receives Approval for High Tech Enterprise Status 23168 1TPI Receives Approval for High Tech Enterprise Status 23168 2FDA to Review Potential New Use of XGEVA AE 28Denosumab 29 at Oncologic Drugs Advisory Committee Meeting 23167 1FDA to Review Potential New Use of XGEVA AE 28Denosumab 29 at Oncologic Drugs Advisory Committee Meeting 23167 2FDA to Review Potential New Use of XGEVA AE 28Denosumab 29 at Oncologic Drugs Advisory Committee Meeting 23167 3FDA to Review Potential New Use of XGEVA AE 28Denosumab 29 at Oncologic Drugs Advisory Committee Meeting 23167 4FDA to Review Potential New Use of XGEVA AE 28Denosumab 29 at Oncologic Drugs Advisory Committee Meeting 23167 5FDA to Review Potential New Use of XGEVA AE 28Denosumab 29 at Oncologic Drugs Advisory Committee Meeting 23167 6FDA to Review Potential New Use of XGEVA AE 28Denosumab 29 at Oncologic Drugs Advisory Committee Meeting 23167 7FDA to Review Potential New Use of XGEVA AE 28Denosumab 29 at Oncologic Drugs Advisory Committee Meeting 23167 8Risk Factors for Vision Loss After Spine Surgery Identified 88223 1Risk Factors for Vision Loss After Spine Surgery Identified 88223 2
... 11 Premier Research Group Limited, the international clinical ... expanded their medical device operations to include full coverage ... has been offering clinical trials services in Europe since ... medical device trials and support services. "Our clients have ...
... ALTOS, Calif., March 11 InteKrin Therapeutics, Inc., a ... obesity, today announced it has completed enrollment of a ... non-TZD selective modulator of PPAR gamma (SPPARM) for the ... a 24 week, high dose active comparator (45mg Actos(R)) ...
Other Medicine Technology:Premier Research Expands its Medical Device Operations to the United States 2InteKrin Therapeutics Announces Enrollment Completion of 360 Patient, 24 week Phase 2b Study 2
Inquire...
... four different Series II Power Supplies. ... and the EPS-6000-II. These high-voltage power ... and constant power operating modes, with ... milliamps maximum current/300 watts maximum power ...
... The PowerPac Universal power supply, 100-120 and ... 0.1-3 A, and 1-500 W. The two-line, ... screen and monitoring of run progress. Built-in ... This unit contains a built-in switch when ...
... power supply, 100-120 and 220-240 ... V, 4-400 mA, and 75 ... built-in switch when using either ... power cord. Power cord and ...
Medicine Products: